Envestnet Portfolio Solutions Inc. Has $4.93 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Envestnet Portfolio Solutions Inc. cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.6% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,280 shares of the company's stock after selling 1,343 shares during the period. Envestnet Portfolio Solutions Inc.'s holdings in HCA Healthcare were worth $4,934,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Farther Finance Advisors LLC increased its holdings in HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock worth $395,000 after purchasing an additional 242 shares during the period. Brighton Jones LLC purchased a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $1,021,000. OLD National Bancorp IN grew its holdings in shares of HCA Healthcare by 5.2% during the first quarter. OLD National Bancorp IN now owns 1,049 shares of the company's stock valued at $362,000 after buying an additional 52 shares during the last quarter. Metropolis Capital Ltd purchased a new position in shares of HCA Healthcare in the first quarter worth about $117,984,000. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in shares of HCA Healthcare by 117.5% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 92,495 shares of the company's stock valued at $27,762,000 after acquiring an additional 49,968 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.30% of the company's stock.

HCA Healthcare Stock Down 1.4%

HCA traded down $5.21 during midday trading on Wednesday, hitting $373.81. 1,294,225 shares of the company's stock traded hands, compared to its average volume of 1,471,749. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The stock's fifty day simple moving average is $363.94 and its 200-day simple moving average is $335.66. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The company has a market cap of $89.93 billion, a PE ratio of 16.62, a price-to-earnings-growth ratio of 1.31 and a beta of 1.49.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the business earned $5.36 earnings per share. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.77%. HCA Healthcare's payout ratio is currently 12.81%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the company an "equal weight" rating in a report on Monday, June 9th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Guggenheim began coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating for the company. Finally, Stephens raised HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus target price of $394.33.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.